Zacks upgraded CONMED's shares to a 'hold' rating on Nov. 19, according to Dakota Financial News.
Here are five points:
1. Zacks stated CONMED's sales were negatively impacted by foreign exchange.
2. CONMED's shares traded up 0.84 percent to $42.17 on Nov. 19.
3. On Nov. 19, 15,771 shares were exchanged.
4. The company has a 12-month-low of $37.94 and a 12-month-high of $60.66.
5. Its 50-day moving average is $44.04 and its 200-day moving average is $52.43.